These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10376183)

  • 1. Fatal torsade de pointes with d,l-sotalol and low potassium.
    Delacrétaz E; Fuhrer J
    Clin Cardiol; 1999 Jun; 22(6):423-4. PubMed ID: 10376183
    [No Abstract]   [Full Text] [Related]  

  • 2. Late proarrhythmia on sotalol therapy triggered by emotional stress.
    Wachowiak-Baszyńska H; Straburzyńska-Migaj E; Ochotny R; Grajek S
    Kardiol Pol; 2011; 69(7):721-3; discussion 724. PubMed ID: 21769797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V; Mermi J; Mewis C; Seipel L
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of torsades de pointes caused by sotalol therapy.
    Cammu G; Geelen P; Baetens P; De Vos J; Demeyer I
    Resuscitation; 1999 Jan; 40(1):49-51. PubMed ID: 10321848
    [No Abstract]   [Full Text] [Related]  

  • 5. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducible induction of "atypical" torsades de pointes by programmed electrical stimulation: a novel form of sotalol-induced proarrhythmia?
    Krishnan SC; Galvin J; McGovern B; Garan H; Ruskin JN
    J Cardiovasc Electrophysiol; 1997 Sep; 8(9):1055-61. PubMed ID: 9300303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsade de pointes with sotalol overdose treated successfully with lidocaine.
    Assimes TL; Malcolm I
    Can J Cardiol; 1998 May; 14(5):753-6. PubMed ID: 9627533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Torsade de pointes and QT syndrome].
    Haverkamp W; Hördt M; Borggrefe M; Breithardt G
    Med Klin (Munich); 1995 Apr; 90(4):240-5. PubMed ID: 7776938
    [No Abstract]   [Full Text] [Related]  

  • 9. A case series of sotalol-induced torsade de pointes in patients with atrial fibrillation--a tale with a twist.
    Tan HH; Hsu LF; Kam RM; Chua T; Teo WS
    Ann Acad Med Singap; 2003 May; 32(3):403-7. PubMed ID: 12854385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsade de pointes and prolonged QT interval from surreptitious use of sotalol: use of drug levels in diagnosis.
    Link MS; Foote CB; Sloan SB; Homoud MK; Wang PJ; Estes NA
    Chest; 1997 Aug; 112(2):556-7. PubMed ID: 9266902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
    Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J
    J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC; Morton BC; Green MS; Tang AS
    Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsade de pointes secondary to d,l-sotalol after catheter ablation of incessant atrioventricular reentrant tachycardia--evidence for a significant contribution of the "cardiac memory".
    Haverkamp W; Hördt M; Breithardt G; Borggrefe M
    Clin Cardiol; 1998 Jan; 21(1):55-8. PubMed ID: 9474467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JTc prolongation with d,l-sotalol in women versus men.
    Lehmann MH; Hardy S; Archibald D; MacNeil DJ
    Am J Cardiol; 1999 Feb; 83(3):354-9. PubMed ID: 10072223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsade de Pointes associated with thyrotoxicosis.
    McLean A; Sceats G
    Intern Med J; 2003 Apr; 33(4):207-8. PubMed ID: 12680990
    [No Abstract]   [Full Text] [Related]  

  • 16. Torsades de pointes following cardioversion: case history and literature review.
    Spearritt D
    Aust Crit Care; 2003 Nov; 16(4):144-9. PubMed ID: 14692159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemiparesis and torsade de pointes under low-dose sotalol therapy].
    Sieber C; Weiss P; Follath F
    Schweiz Med Wochenschr; 1990 Sep; 120(38):1397-9. PubMed ID: 1699270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torsade de pointes: the clinical considerations.
    Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using the dog as its own control.
    Verduyn SC; Vos MA; van der Zande J; Kulcsàr A; Wellens HJ
    J Am Coll Cardiol; 1997 Nov; 30(6):1575-84. PubMed ID: 9362418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsade de pointes--a rare presentation of primary hyperaldosteronism.
    Kornelius E; Chen KS; Yang YS; Huang CN
    Am J Emerg Med; 2012 Jan; 30(1):257.e5-7. PubMed ID: 21159461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.